UJ.com

Top 2 

                        FRIDAY, MARCH 29, 2024
Make Homepage /  Add Bookmark
Front Page
Nation
Business
Search
Subscription
Advertising
About us
Copyright
Contact
 

   Username:
   Password:


Registration

 
GISMETEO.RU
UJ Week
Top 1   

    
Business    

Biopharma collects enough plasma from patients to start making COVID drug
Journal Staff Report

KYIV, Nov 25 – Biopharmaceutical company Biopharma has collected enough plasma for the production of the first batch of hyperimmune immunoglobulin, a drug to treat COVID-19, Kostiantyn Yefymenko, Biopharma president, said.

The lack of plasma collected from recovered COVID-19 patients has been earlier cited by the company as the main reason why Biopharma had been delaying production of COVID-19 treatment drug.




Log in

Print article E-mail article


Currencies (in hryvnias)
  28.03.2024 prev
USD 39.23 39.14
RUR 0.425 0.422
EUR 42.44 42.44

Stock Market
  27.03.2024 prev
PFTS 507.0 507.0
source: PFTS

OTHER NEWS

Ukrainian Journal   
Front PageNationBusinessEditorialFeatureAdvertisingSubscriptionAdvertisingSearchAbout usCopyrightContact
Copyright 2005 Ukrainian Journal. All rights reserved
Programmed by TAC webstudio